For most patients with end-stage renal disease patients (ESRD), the age of a living donor (ranging from 18-64 years) has an insignificant effect on the long-term health of a transplanted kidney, according to researchers in British Columbia, Canada.
NATIONAL HARBOR, Md.—Rapid anemia management (RAM) for patients with end-stage renal disease within seven days of hospital discharge decreases their rate of readmission, according to findings presented at the National Kidney Foundation 2012 Spring Clinical Meetings.
NATIONAL HARBOR, Md.—Nearly two thirds of patients with end-stage renal disease (ESRD) experience a drop in hemoglobin (Hb) level after hospitalization, and it may take months after hospitalization for Hb levels to recover, researchers reported at the National Kidney Foundation 2012 Spring Clinical Meetings.
Advanced glycation end products (AGEs) are byproducts of non-enzymatic chemical reactions between sugars and amino acids, lipids, or DNA.
The FDA will be piloting three products for the treatment of end-stage renal disease (ESRD), including an artificial kidney, as part of an ongoing program to expedite the availability of medical technology.
This is the title of a scheduled May 12 session at the National Kidney Foundation’s 2012 Spring Clinical Meetings.
For some, freedom from the hassles of treatment is worth a shorter life expectancy, study finds.
Research has shown that individuals who exercise have lower risk for chronic diseases than individuals who do not exercise.
Thousands of older adults with end-stage renal disease are not receiving kidney transplants because of outdated medical biases, according to a new study.
PHILADELPHIA—Acute kidney injury (AKI), also known as acute renal failure, requiring dialysis has become more common than end-stage renal disease (ESRD) requiring renal replacement therapy (RRT), according to findings presented at Kidney Week 2011.
